Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes
Georgios Tsamos, Dimitra Vasdeki, Theocharis Koufakis, et al.
Metabolites (2023) Vol. 13, Iss. 4, pp. 517-517
Open Access | Times Cited: 11

Showing 11 citing articles:

Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
Sara Volpe, Giuseppe Lisco, Margherita Fanelli, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Computer-Aided Strategy on 5-(Substituted benzylidene) Thiazolidine-2,4-Diones to Develop New and Potent PTP1B Inhibitors: QSAR Modeling, Molecular Docking, Molecular Dynamics, PASS Predictions, and DFT Investigations
Nour-El Houda Derki, Aicha Kerassa, Salah Belaıdı, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 822-822
Open Access | Times Cited: 3
Association of Hematological Biomarkers of Inflammation with 10-Year Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: The ARIC Study
Jia-Jie Wang, Zhichao Zheng, Ying Zhang
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 4247-4256
Open Access | Times Cited: 2
Deep learning for predicting fibrotic progression risk in diabetic individuals with metabolic dysfunction-associated steatotic liver disease initially free of hepatic fibrosis
Ruihong Dai, Miaomiao Sun, Mei Lu, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e34150-e34150
Open Access | Times Cited: 2
CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion
Hyunjin Rho, Seung‐Yeon Kim, Seung Up Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Roles of PPARα and PPARγ As Regulator of Free Fatty Acids in Nonalcoholic Steatohepatitis
Hung Thai Vu, Vien Duc Nguyen, Tsutomu Matsubara
(2023)
Open Access | Times Cited: 2
Effective treatment for fatty liver of liraglutide via inhibiting endoplasmic reticulum stress, oxidative stress and apoptosis pathways
Juan Li, Jiaxin Xu, Fangfang Zhu, et al.
Archives of Medical Science (2024)
Open Access
Diabetes mellitus bei Patient:innen mit Leberzirrhose – eine besondere therapeutische Herausforderung
Claudia Ress
Journal für Gastroenterologische und Hepatologische Erkrankungen (2024) Vol. 22, Iss. 2, pp. 49-55
Closed Access
Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1876-1876
Open Access
Saroglitazar - A novel treatment for non-alcoholic steatohepatitis
Shifa Noorani, Manasa Ankam, C. H. S. V. Ganesh, et al.
AIP conference proceedings (2024) Vol. 3232, pp. 060019-060019
Closed Access
Protective Effect of High Adherence to Mediterranean Diet on the Risk of Incident Type-2 Diabetes in Subjects with MAFLD: The Di@bet.es Study
Ana Lago‐Sampedro, Wasima Oualla‐Bachiri, Sara García‐Serrano, et al.
Nutrients (2024) Vol. 16, Iss. 21, pp. 3788-3788
Open Access
Page 1

Scroll to top